Enhancing the QUAlity and Transparency Of health Research
Use your browser's Back button to return to your search results
|Reporting guideline provided for?
(i.e. exactly what the authors state in the paper)
|Reporting of patent landscapes.|
|Full bibliographic reference||Smith JA, Arshad Z, Trippe A, Collins GS, Brindley DA, Carr AJ. The Reporting Items for Patent Landscapes statement. Nat Biotechnol. 2018;36(11):1043-1047.|
|Reporting guideline acronym||RIPL|
|Study design||Patent landscapes|
|Applies to the whole report or to individual sections of the report?||Whole report|
|Additional information||Read the background paper by the reporting guideline authors assessing the quality of reporting in patent landscapes in the life sciences:
Smith JA, Arshad Z, Thomas H, Carr AJ, Brindley DA. Evidence of insufficient quality of reporting in patent landscapes in the life sciences. Nat Biotechnol. 2017;35(3): 210-214. PMID: 28267720
|Record last updated on||November 19, 2021|
Some reporting guidelines are also available in languages other than English. Find out more in our Translations section.